CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-11 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $35.10 | $48K | 107,700 |
| 2022-01-11 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 223,630 | ||
| 2022-01-05 | Pang Phillip Chief Medical Officer | Option exercise | +5,000 | $1.53 | $8K | 97,777 |
| 2022-01-05 | Pang Phillip Chief Medical Officer | Sale | −4,600 | $37.14 | $171K | 93,177 |
| 2022-01-05 | Pang Phillip Chief Medical Officer | Sale | −400 | $37.78 | $15K | 92,777 |
| 2022-01-05 | Pang Phillip Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,000 | 67,591 | ||
| 2021-12-28 | Virgin Herbert EVP, Research & CSO | Option exercise | +1,375 | $1.53 | $2K | 109,075 |
| 2021-12-28 | Virgin Herbert EVP, Research & CSO | Sale | −1,375 | $39.95 | $55K | 107,700 |
| 2021-12-28 | Virgin Herbert EVP, Research & CSO | Option exercise · Stock Option (Right to Buy) | −1,375 | 225,005 | ||
| 2021-12-20 | NELSEN ROBERT Director | Other acquisition | +102,041 | 247,546 | ||
| 2021-12-20 | NELSEN ROBERT Director | Other disposition | −762,233 | 8,239,380 | ||
| 2021-12-20 | NELSEN ROBERT Director | Other disposition | −987,767 | 10,677,283 | ||
| 2021-12-20 | NELSEN ROBERT Director | Other acquisition | +102,041 | 244,172 | ||
| 2021-12-20 | ARCH Venture Partners IX, LLC 10% owner | Other disposition | −762,233 | 8,239,380 | ||
| 2021-12-20 | ARCH Venture Partners IX, LLC 10% owner | Other disposition | −987,767 | 10,677,283 | ||
| 2021-12-20 | ARCH Venture Partners IX, LLC 10% owner | Other acquisition | +45,703 | 116,058 | ||
| 2021-12-20 | ARCH Venture Partners IX, LLC 10% owner | Other acquisition | +15,504 | 38,589 | ||
| 2021-12-20 | SVF Endurance (Cayman) Ltd 10% owner | Sale | −400,022 | $52.73 | $21.1M | 22,216,644 |
| 2021-12-20 | SATO VICKI L Director | Sale | −5,173 | $51.87 | $268K | 1,561,093 |
| 2021-12-20 | SATO VICKI L Director | Sale | −1,300 | $54.35 | $71K | 1,559,793 |
Page 31 of 54 · 1,063 trades